Companies: 10,795·Total market cap: $144.5T
Agilent Technologies, Inc.

Agilent Technologies, Inc.

ANYSEHealthcare● Active
$135.33
$-0.12(-0.08%)
Market Cap$38.2B
P/E Ratio—
52W High$160.27
52W Low$108.35
Overview

Agilent Technologies, Inc. (A) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

A · cash on hand · updated Oct 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$1.79B▲ +34.6% vs prior year
FY · as of Oct 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$1.79B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+34.6%
vs prior fiscal year
Latest Quarter
$1.81B
Q2 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: October 31, 2025

Net cash vs debt

Cash & ST Investments$1.79BCash on Hand
Total Debt$3.35BTotal Debt
Net Cash / Net Debt−$1.56BNet Debt Position
Cash vs Debt Ratio
Cash 35%Debt 65%

Agilent Technologies, Inc. carries a net debt position of $1.56B. Total debt ($3.35B) exceeds cash on hand ($1.79B). Agilent Technologies, Inc. cash vs debt ratio: 35% cash / 65% debt.

Net Cash = Cash & ST Investments − Total Debt$1.79B − $3.35B = −$1.56B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
A annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Oct 31, 2025Latest$1.79B+34.6%
Oct 31, 2024$1.33B-16.4%
Oct 31, 2023$1.59B+51.0%
Oct 31, 2022$1.05B-33.1%
Oct 31, 2021$1.57B+9.3%
A cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Agilent Technologies, Inc.
Agilent Technologies, Inc.YOU
A
$1.79B4.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Agilent Technologies, Inc. (A) cash on hand as of October 31, 2025 is $1.79B, comprising $1.79B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Agilent Technologies, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Agilent Technologies, Inc. cash reserves or cash position.

Agilent Technologies, Inc. annual cash on hand history shows increased +34.6% in 2025: increased +34.6% in 2025. Agilent Technologies, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Agilent Technologies, Inc. carries total debt of $3.35B against cash of $1.79B, resulting in a net debt position of -$1.56B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

A cash on hand · 5 questions

As of October 31, 2025, Agilent Technologies, Inc. (A) has $1.79B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1.79B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (April 30, 2026): $1.81B. Data sourced from the annual 10-K filing via FMP.

A cash on handA cash reservesA cash 2025how much cash does A have

▸ Source: FMP /balance-sheet-statement · US GAAP · Agilent Technologies, Inc. · Agilent Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: October 31, 2025